GlassScriptPhysician profile
Kendra L Rininger
NPI 1528264322
$1,699.25
in general payments reported to CMS, 2019-2025
20 companies · $281 in 2025
The $281 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $102 · 2022: $450 · 2023: $263 · 2024: $602 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,052 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,051.89 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $500.32 | 2023-2024 | |
| Allergan, INC. | $317.91 | 2022 | |
| Sun Pharmaceutical Industries INC. | $191.27 | 2021-2025 | Odomzo, Blu-U |
| Galderma Laboratories, L.P. | $138.40 | 2025 | Dysport |
| Lilly USA, LLC | $83.60 | 2021-2024 | Taltz, Olumiant, Zepbound |
| Janssen Biotech, INC. | $77.25 | 2021-2023 | Tremfya |
| Genzyme Corporation | $75.26 | 2022-2023 | |
| Hologic Sales and Service, LLC | $45.76 | 2024 | Omni Hysteroscope |
| Incyte Corporation | $32.95 | 2022-2023 | Opzelura |
| Paratek Pharmaceuticals, INC. | $31.28 | 2023 | Nuzyra |
| Ucb, INC. | $30.55 | 2022-2023 | Cimzia |
| Novo Nordisk INC | $29.17 | 2024 | Wegovy |
| Amgen INC. | $22.29 | 2023 | Otezla |
| Mayne Pharma Commercial LLC | $21.49 | 2023 | |
| Leo Pharma INC. | $21.29 | 2021 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $20.48 | 2025 | Libtayo |
| Vyne Pharmaceuticals INC. | $17.97 | 2021 | |
| Axonics, INC. | $14.94 | 2024 | Axonics, Bulkamid |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $13.81 | 2021 | |
| Coopersurgical, INC. | $13.26 | 2024 | Paragard T 380a |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kendra Rininger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.